Caricamento...
Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways
BACKGROUND: In previous studies, we have shown that the combination of metformin and gefitinib inhibits the growth of bladder cancer cells. Here we examined whether the metformin analogue phenformin, either used alone or in combination with gefitinib, could inhibit growth of bladder cancer cells. ME...
Salvato in:
| Pubblicato in: | Cancer Commun (Lond) |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6062982/ https://ncbi.nlm.nih.gov/pubmed/30053908 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-018-0319-7 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|